The preparation of Geer cow urine distillation (CUD) and an investigation of inorganic metal ion in Geer CUD

Introduction

The World Health Organization (WHO) defines biomedical waste as any waste generated during healthcare activities. Infectious materials like blood, bodily fluids, or tissues. Sharps like used needles, syringes, scalpels, and other sharp objects. Pharmaceuticals including expired, unused, or contaminated medicines. Radioactive materials used for diagnostics or treatments. In India, the Biomedical Waste Management and Handling Rules, 1998 provide guidelines for handling such waste, specifying how healthcare facilities should manage waste generated during diagnosis, treatment, immunization or research activities. Waste should be segregated at the source into different categories (e.g., sharps, pharmaceutical waste and infectious waste). It's also commonly known as medical waste, healthcare waste or infectious waste. Different types of biomedical waste must be placed in specific color-coded bins for easy identification and safety. Waste must be stored in proper containers to prevent contamination or exposure. Waste must be transported safely to disposal or treatment facilities. Waste is treated to reduce its hazardous effects (e.g., sterilization or incineration). Final disposal involves rendering the waste safe for the environment, typically through methods like incineration or landfilling. Direct contact with contaminated needles or tissues can lead to the spread of diseases such as HIV, Hepatitis B & C, Tuberculosis, and others. Improper disposal of pharmaceuticals or chemicals can contaminate water supplies, soil and air. Healthcare workers, sanitation staff and waste handlers face a higher risk of exposure. Rag pickers and people in the surrounding area are also at risk of coming into contact with waste improperly discarded. Doctors, nurses, and other staff who handle biomedical waste face potential exposure to infections and hazardous substances. Sanitation Workers and Waste Handlers, t hose involved in cleaning and transporting the waste also risk exposure if proper safety procedures aren't followed.

areas without proper waste management infrastructure. Gomutra is not classified as a toxic waste and has shown immune-modulatory effects in experimental settings. However, while traditional systems like Ayurveda regard it as therapeutic, its use in modern clinical medicine remains investigational and must be treated with scientific scrutiny and care. Gomutra is believed to exhibit antibacterial, antifungal and germicidal effects. It contains Urea as wellknown antimicrobial agent. In higher concentrations, it can denature proteins and damage microbial cell walls. Creatinine may contribute mildly to antimicrobial action, though its exact role is less studied. Swarn Kshar (Aurum hydroxide) which traditionally believed to boost immunity and have antimicrobial effects. However, scientific validation is limited. Carbolic acid (phenol) and other phenolic compounds: Known disinfectants with strong germicidal properties. Calcium and Manganese act as trace minerals essential for various physiological functions. Gomutra has been studied (primarily in animal models and in vitro) for its potential anti-cancer effects, which may be due to Uric Acid which acts as an antioxidant, scavenging free radicals that may lead to DNA damage and cancer, Allantoin is natural compound with cell-proliferation and tissue-repair properties, often used in wound healing. It's claimed to help prevent abnormal cell growth, but evidence for anti-cancer effects is limited and not clinically validated. It may support wound healing and cellular integrity. Gomutra contains compounds that, have antimicrobial, wound-healing, and antioxidant properties. These support traditional claims to some extent, especially in Ayurvedic or ethano-medical contexts. However, modern medicine requires rigorous clinical evidence before gomutra can be recommended for therapeutic use especially for serious conditions like cancer. The composition of cow urine encompasses approximately 95% aqueous phase, 2.5% urea content, with the remaining 2.5% comprising a complex mixture of minerals, salts, hormones, and enzymes. Biochemical analyses indicate the presence of sodium (Na), nitrogen (N), sulfur (S), potassium (K), copper (Cu), calcium (Ca), phosphate (PO 4 ), manganese (Mn), iron (Fe), silicon (Si), chlorine (Cl), magnesium (Mg), aurum hydroxide (Au(OH) 3 ), citric acid (C 6 H 8 O 7 ), succinic acid (C 4 H 6 O 4 ), hippuric acid (C 9 H 9 No 3 ), maleic acid (C 4 H 4 O 4 ), tartaric acid (C 4 H 6 O 6 ), carbolic acid (C 6 H 6 O), as well as vitamins A, B, C, D, and E, lactose, enzymes, creatinine, and various hormones.

Materials and Methods 1. Materials and Chemicals

Two necked round bottom flask, kipp's apparatus, glass connector, coiled condenser, zeolite column, glass beakers, TDS measurement machine, pH meter, heating mantal, cotton, whatmann filter paper 41. Electrical s/w on ICP instrument, fresh cow urine, silica, Aluminum oxide, stones, dust, deionized water, plasma gas, etc.

Methodology for CUD preparation

The fresh cow urine was firstly added into cleaned two necked round bottom flask. Then assembly was connected. And zeolite column was also prepared and assembled. Geer Cow urine was heated by using heating mantal instrument. After boiling of cow urine, the vapours of cow urine was passed through kipp's apparatus. Then vapours was cooled and converted into liquid form and settled into zeolite column through passing glass connecter and coiled condenser. Then fractions of CUD about 25-30 ml was collected into separate beakers.

Procedure for inductively coupled plasma (ICP)

Sample preparation and analytical assessment: dilute the CUD sample was collected by distillation to 100-fold using deionized water (e.g., transfer 1 mL of the sample into 100 mL of DI water). Initiate the electrical software on the inductively coupled plasma (ICP) instrument. Manually activate the plasma gas and perform a purging sequence for the plasma gas. Control the chiller's operational status (on/off). Ensure the instrument has been energized and purged for a minimum duration of 2 hours. Assemble the tubing as per the provided guidelines in the Hardware Evaluation Protocol (HEP) within the ITEVA software for sampling. After confirming all interlock systems indicate green status, select the plasma icon followed by activation of the plasma. Access the ITEVA control center and select the analyst option. Calibrate the measurement methodology by selecting calibration from the 'run' menu. Aspirate the blank standard from the run sequence, subsequently repeat this for the high standard, and finalize the process by selecting done. Select 'unknown sample' from the run menu, designate the sample identifier, and initiate the run sequence. Post-analysis, perform a rinsing procedure with DI water. Select the plasma icon and deactivate the plasma. Proceed to power down the instrument.

Results

The fractions of the CUD sample were segregated into distinct beakers for analytical purposes. The total dissolved solids (TDS) and pH of these samples were quantitatively assessed utilizing TDS and pH meters. Furthermore, the toxicity of these samples was evaluated employing the iodine assay method. Sensory observations regarding the color and odor of the collected CUD samples were conducted. The comprehensive results regarding the CUD samples are enumerated as follows.

Discussion

The analytical results indicate that the processed Geer Cow Urine Distillate (CUD) meets or surpasses international quality standards set by the World Health Organization (WHO) for pH and TDS. The reduction in TDS from 24.8 g/kg in fresh urine to 0.409 g/kg in CUD signifies effective distillation and purification. The pH of CUD (8.0) is within the permissible alkaline range, suitable for potential therapeutic or agricultural applications. Sensory analysis revealed that the CUD is colorless, odorless, and only slightly bitter, enhancing its acceptability for further bioactive investigations. Importantly, the absence of toxicity, as indicated by the iodine assay, further supports the safety profile of CUD. These observations collectively suggest that the CUD preparation is of high quality and may serve as a viable candidate for pharmacological, antimicrobial or biostimulant applications. Elemental analysis indicated the presence of both macro and trace metallic elements. Inorganic elements such as calcium, potassium, sodium, magnesium, and iron were expected due to their essential physiological roles in bovine metabolism and their consistent dietary intake. However, the detection of toxic elements such as arsenic (As), cadmium (Cd), and lead (Pb), even in trace amounts, necessitates careful evaluation due to their potential bioaccumulative and toxic effects. Their occurrence is likely linked to environmental exposure or contaminated feed, underscoring the need for stringent monitoring of bovine diets and habitat quality. The presence of rare metals such as gallium (Ga), indium (In), and bismuth (Bi) is noteworthy and may reflect geochemical peculiarities of the region where the bovines were raised. Variability in metal concentrations among samples further highlights the role of geographical and physiological factors, such as age and health status, in determining urine composition. Sensory analysis of colour and odour, although qualitative, contributes to understanding the physical characteristics and potential usability of cow urine in traditional medicine, agriculture, or industry. Distinct odours and coloration may correlate with the metabolic state of the animal or the presence of specific compounds, such as volatile organic acids or nitrogenous waste.

In conclusion, the chemical and elemental diversity observed in the CUD samples emphasizes the complex nature of bovine urine as a biological fluid. While its composition is influenced by several factors including diet, climate and health the presence of both beneficial and potentially harmful constituents necessitates cautious utilization, especially in therapeutic or agricultural contexts. Future studies should aim for broader sample sizes, include longitudinal monitoring and incorporate advanced analytical techniques such as ICP-MS and GC-MS to further elucidate the biochemical dynamics of cow urine.

Conclusion

The comprehensive physicochemical and sensory evaluation of Geer Cow Urine Distillate (CUD) demonstrates that it meets the acceptable quality criteria set by WHO standards, particularly in terms of pH and TDS. The distillation process effectively reduces the total dissolved solids, enhances organoleptic properties and eliminates detectable toxicity, indicating a high level of purification and suitability for various applications. The presence of essential macroelements like calcium, magnesium, potassium and iron reflects the physiological importance of these constituents in bovine metabolism and validates their natural origin. However, the detection of trace levels of potentially hazardous elements such as arsenic, cadmium, and lead raises concerns about environmental and dietary contamination. This highlights the critical need for continuous monitoring of bovine feed and environmental conditions to ensure safety and minimize toxic accumulation.

Overall, the findings support the potential of CUD as a safe and bioactive agent, warranting further investigation into its pharmacological, antimicrobial, and agricultural utility, provided that rigorous quality control is maintained in its preparation

Acknowledgement

AcknowledgmentsAuthors are thankful to the management of BJS ARTS, SCIENCE & COMMERCE COLLEGE WAGHOLI PUNE, for providing necessary facilities for doing this work.Funding: This work was partly supported by funding from the GoVidnyan Sashodhan Sanstha, Pune-411008. Declaration

References

1. Edwin J, Sheej E, Vaibhav T, Rajesh G, Emmannual T. Antioxidant and antimicrobial activities of cow urine. Global J Pharmacology. 2008;2:20-22.
2. Kanaujia A, Upadhyay SK. Comparative assessment of laboratory produced and commercially available cow urine distillates. Int J Adv Res. 2018;6(8):404-406.
3. Chauhan RS, Dhama K, Singhal L. The Indian Cow. Scientific and Economic Journal. 2009;19:22-58.
4. Chauhan RS. Panchgawya therapy (Cowpathy), current status and future directions. Indian Cow. 2004;1:3-7.
5. Greenwood D, Slack RCB, Peutherer JF, Duguid JP. Medical Microbiology: A guide to microbial infections: pathogenesis, immunity, laboratory diagnosis and control. Edinburgh: Churchill Livingstone; 1992.
6. Bhadauria H. Cow urine-A magical therapy. Int J Cow Sci. 2002;1:6-32.
7. Nationalt Center for Miljø og Energi, Aarhus Universitet, Institut for Bioscience. Bertini I, Gray HB, Stiefel EI, Valentine JS. Biological inorganic chemistry: structure and reactivity. Sausalito, CA: University Science Books; 2007.
8. Birkmose T, Hjort-Gregersen K, Stefanek K. Biomasse til biogasanlaeg i Danmark-på kort og langt sigt. Agrotech. 2013. Available from: https://ens.dk/sites/ens.dk/files/Bioenergi/biomasser_til _biogasanlaeg.pdf
9. Birkmose T, Tybirk P. Svinegyllens sammensaetningIndhold og dokumentation. Aarhus: Videncenter for Svineproduktion; 2013.
10. Brandt A. New recommendation for phasing out zinc oxide for young pigs. Laegemiddelstyrelsen. 2017. Available from: https://laegemiddelstyrelsen.dk/en/news/2017/newrecommendation-for-phasing-out-zinc-oxide-for-youngpigs/
11. Burton CH, Turner CH. Manure management: Treatment strategies for sustainable agriculture. 2nd ed. Wrest Park, Silsoe, UK: Silsoe Research Institute; 2003.
12. Prashith Kekuda TR, Nishanth BC, Praveen Kumar SV, Kamal D, Sandeep M, Megharaj HK. Cow urine concentrate: A potent agent with antimicrobial and anthelmintic activity. J Pharm Res. 2010;3:1025-1027.
13. Pandey GS, Chunekar KC. Bhav Prakash Nighantu (Indian Materia Medica) of Sri Bhavamisra (c.16001600 AD)-Ath Mutravargh. Vol. 18. Varanasi: Chaukhamba Bharati Academy; 2009. p. 778.
14. Shukla AV, Tripathi RD. Caraka Samhita of Agnivesh. Vol. 1. Delhi: Chaukhamba Sanskrit Pratishthan; 1997. p. 45.
15. Bhadauria H. Cow urine-A magical therapy. Vishwa Ayurveda Parishad. Int J Cow Sci. 2002;1:32-36.
16. Chauhan RS. Panchagavya therapy (Cowpathy)-Current status and future directions. Indian Cow. 2004;1:3-7.
17. Jain NK, Gupta VB, Garg R, Silawat N. Efficacy of cow urine therapy on various cancer patients in Mandsaur district, India: A survey. Int J Green Pharm. 2010;4:29-35.
18. Misra BS, Shastri KA, Lochan K, Choudhary AK. Bhaisajyaratnavali of Govinda Dasji. Vol. 2. Varanasi: Chaukhamba Sanskrit Bhawan; 2006. p. 51-52.
19. Chauhan RS, Garg N. Cow therapy as an alternative to antibiotics. Bangalore, Karnataka: Indian Science Congress; 2003.
20. Chawla PC. Risorine-A novel CSIR drug curtails TB treatment. CSIR News. 2010 Mar;60:52.
21. Ganaie JA, Shrivastava VK. Effects of gonadotropinreleasing hormone conjugate immunization and bioenhancing role of Kamdhenu ark on estrous cycle, serum estradiol and progesterone levels in female Mus musculus. Iran J Reprod Med. 2010;8:70-75.
22. Khan A, Srivastava V. Antitoxic and bioenhancing role of Kamdhenu ark (cow urine distillate) on fertility rate of male mice (Mus musculus) affected by cadmium chloride toxicity. Int J Cow Sci. 2005;1:43-46. Available from: http://www.patentstorm.us/patents/6896907/description. html [last accessed 2010 Sep 2].